Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System

Area of Science:

• Biotechnology
• Cancer Research
• Neuro-oncology

Background:

• Glioblastoma is a highly aggressive brain cancer.
• Targeting glioblastoma tumor-initiating cells (TICs) is crucial for effective drug development.
• Current methods for culturing glioblastoma TICs are costly and challenging for large-scale drug discovery.

Purpose of the Study:

• To develop a cost-effective and scalable method for culturing glioblastoma TICs.
• To improve the quality and yield of glioblastoma TICs for drug discovery applications.
• To overcome the limitations of existing cell culturing technologies.

Main Methods:

• Utilized microscale alginate hydrogel tubes (AlgTubes) for glioblastoma TIC culture.
• Maintained long-term culturing of TICs for approximately 50 days and 10 passages.
• Assessed cell viability, growth rate, and stem cell properties.

Main Results:

• Achieved a high growth rate with approximately 700-fold expansion in 14 days.
• Maintained high cell viability throughout the long-term culture period.
• Obtained a high volumetric yield of approximately 3.0 × 10^8 cells/mL.
• Preserved the essential stem cell properties of the cultured glioblastoma TICs.

Conclusions:

• The AlgTubes method offers significant advancements over current glioblastoma TIC culturing techniques.
• This novel method enables the scalable and affordable production of high-quality glioblastoma TICs.
• The developed technique is promising for accelerating glioblastoma drug discovery and development.